R. Reshma

654 total citations
33 papers, 509 citations indexed

About

R. Reshma is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, R. Reshma has authored 33 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Infectious Diseases and 9 papers in Organic Chemistry. Recurrent topics in R. Reshma's work include Tuberculosis Research and Epidemiology (13 papers), Cancer therapeutics and mechanisms (9 papers) and Metal complexes synthesis and properties (6 papers). R. Reshma is often cited by papers focused on Tuberculosis Research and Epidemiology (13 papers), Cancer therapeutics and mechanisms (9 papers) and Metal complexes synthesis and properties (6 papers). R. Reshma collaborates with scholars based in India, Sweden and Slovakia. R. Reshma's co-authors include Dharmarajan Sriram, Perumal Yogeeswari, R. Schnell, Vagolu Siva Krishna, Variam Ullas Jeankumar, Shalini Saxena, Arish Dasan, R. Selwin Joseyphus, G. Schneider and Janupally Renuka and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

R. Reshma

31 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Reshma India 15 241 208 129 57 55 33 509
Leentje Persoons Belgium 15 280 1.2× 323 1.6× 178 1.4× 76 1.3× 53 1.0× 66 793
Baiyuan Yang United States 10 235 1.0× 253 1.2× 117 0.9× 64 1.1× 67 1.2× 17 580
Anne Drumond Villela Brazil 14 244 1.0× 128 0.6× 260 2.0× 142 2.5× 45 0.8× 32 453
Matteo Santucci Italy 14 241 1.0× 83 0.4× 65 0.5× 98 1.7× 54 1.0× 26 540
Shamila S. Gunatilleke United States 9 207 0.9× 195 0.9× 106 0.8× 129 2.3× 107 1.9× 10 581
Dengfeng Dou United States 17 248 1.0× 230 1.1× 119 0.9× 35 0.6× 31 0.6× 28 656
Xiaoyi Deng United States 13 384 1.6× 151 0.7× 184 1.4× 122 2.1× 30 0.5× 19 648
Yoshihiko Yagi United States 10 156 0.6× 435 2.1× 117 0.9× 80 1.4× 60 1.1× 13 681
Surendra Dawadi United States 13 226 0.9× 117 0.6× 115 0.9× 58 1.0× 26 0.5× 13 396
Nishad Thamban Chandrika United States 12 191 0.8× 280 1.3× 143 1.1× 70 1.2× 26 0.5× 28 548

Countries citing papers authored by R. Reshma

Since Specialization
Citations

This map shows the geographic impact of R. Reshma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Reshma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Reshma more than expected).

Fields of papers citing papers by R. Reshma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Reshma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Reshma. The network helps show where R. Reshma may publish in the future.

Co-authorship network of co-authors of R. Reshma

This figure shows the co-authorship network connecting the top 25 collaborators of R. Reshma. A scholar is included among the top collaborators of R. Reshma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Reshma. R. Reshma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jolly, S., et al.. (2025). Emerging paradigms in renewable hydrogen production: Technology, challenges, and global impact. Next Energy. 8. 100343–100343. 2 indexed citations
3.
Reshma, R., et al.. (2022). Mycobacterium tuberculosis KasA as a drug target: Structure-based inhibitor design. Frontiers in Cellular and Infection Microbiology. 12. 1008213–1008213. 9 indexed citations
5.
Reshma, R., Thomas Lundbäck, Hanna Axelsson, et al.. (2020). A FabG inhibitor targeting an allosteric binding site inhibits several orthologs from Gram-negative ESKAPE pathogens. Bioorganic & Medicinal Chemistry. 30. 115898–115898. 18 indexed citations
6.
Krishna, Vagolu Siva, et al.. (2020). Synthesis, in vitro, and in vivo (Zebra fish) antitubercular activity of 7,8-dihydroquinolin-5(6H)-ylidenehydrazinecarbothioamides. Bioorganic Chemistry. 96. 103626–103626. 14 indexed citations
7.
Reshma, R., Variam Ullas Jeankumar, Nidhi Kapoor, et al.. (2017). Mycobacterium tuberculosis lysine-ɛ-aminotransferase a potential target in dormancy: Benzothiazole based inhibitors. Bioorganic & Medicinal Chemistry. 25(10). 2761–2771. 23 indexed citations
8.
Krishna, Vagolu Siva, et al.. (2017). Lead identification and optimization of bacterial glutamate racemase inhibitors. Bioorganic & Medicinal Chemistry. 26(1). 177–190. 10 indexed citations
9.
Vidyacharan, Shinde, Chandan Adhikari, Vagolu Siva Krishna, et al.. (2017). A robust synthesis of functionalized 2H-indazoles via solid state melt reaction (SSMR) and their anti-tubercular activity. Bioorganic & Medicinal Chemistry Letters. 27(7). 1593–1597. 33 indexed citations
10.
Reshma, R., et al.. (2017). Profiling of in vitro activities of urea-based inhibitors against cysteine synthases from Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry Letters. 27(19). 4582–4587. 18 indexed citations
11.
Krishna, Vagolu Siva, et al.. (2017). Identification and development of benzoxazole derivatives as novel bacterial glutamate racemase inhibitors. European Journal of Medicinal Chemistry. 145. 23–34. 28 indexed citations
12.
Reshma, R., et al.. (2017). Synthesis and evaluation of 4′,5′-dihydrospiro[piperidine-4,7′-thieno[2,3-c]pyran] analogues against both active and dormant Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry. 26(8). 1462–1469. 16 indexed citations
13.
Reshma, R., Sujogya Mishra, Neeraj S. Thakur, et al.. (2016). Modulatory role of leptin on ovarian functions in water buffalo (Bubalus bubalis). Theriogenology. 86(7). 1720–1739. 13 indexed citations
14.
Reshma, R., Perumal Yogeeswari, & Dharmarajan Sriram. (2016). Design and development of novel inhibitors for the treatment of latent tuberculosis. International Journal of Mycobacteriology. 5. S121–S122. 2 indexed citations
15.
Jeankumar, Variam Ullas, R. Reshma, Rahul Vats, et al.. (2016). Engineering another class of anti-tubercular lead: Hit to lead optimization of an intriguing class of gyrase ATPase inhibitors. European Journal of Medicinal Chemistry. 122. 216–231. 27 indexed citations
16.
Abdu-Allah, Hajjaj H.M., Bahaa G. M. Youssif, Mostafa Abdelrahman, et al.. (2016). Synthesis and anti-mycobacterial activity of 4-(4-phenyl-1H-1,2,3-triazol-1-yl)salicylhydrazones: revitalizing an old drug. Archives of Pharmacal Research. 40(2). 168–179. 19 indexed citations
17.
Reshma, R., et al.. (2016). Design and development of new class of Mycobacterium tuberculosis l-alanine dehydrogenase inhibitors. Bioorganic & Medicinal Chemistry. 24(18). 4499–4508. 11 indexed citations
18.
19.
Jeankumar, Variam Ullas, R. Reshma, Janupally Renuka, et al.. (2014). Enabling the (3 + 2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure activity profiling. Organic & Biomolecular Chemistry. 13(8). 2423–2431. 24 indexed citations
20.
Reshma, R., et al.. (2009). Aqua{6,6′-dimethoxy-2,2′-[ethane-1,2-diylbis(nitrilomethylidyne)]diphenolato}(4-hydroxybenzoato)manganese(III). Acta Crystallographica Section E Structure Reports Online. 65(9). m1110–m1111. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026